Home | Welcome to Contract Pharma   
Last Updated Sunday, April 20 2014
Print

Frontage Labs Adds Senior Clinical Staff



Published July 2, 2013
Related Searches: Development www.contractpharma.com pharma companies Phase I
George Laskaris has been named senior director of Frontage Laboratories Biometrics Services. Mr. Laskaris has more than 20 years of programming, statistical and data management experience with pharmaceutical and CROs. In this new role, he will lead operational management, infrastructure development and growth strategies for the company’s clinical programming, statistics and data management groups.
 
Mr. Laskaris joins the company from PRA International, where he managed a team of statistical programmers. Previously, he worked at several global pharma companies, serving in a variety of management roles in clinical research positions.
 
Alma Villasin, RN, BSN, MBA, has been named director of Clinical Operations. She will be responsible for day-to-day oversight of clinical operations and staff training for all study activities, and for the company’s clinical operations expansion initiative.
 
Most recently, Ms. Villasin served as clinical operations director for Duke Clinical Research Unit (DCRU), where she oversaw the feasibility and conduct of Phase I-III trials. Prior to that, Ms. Villasin worked at Thomas Jefferson University as manager of the clinical trials groups, where she lead a research collaboration on global cardiovascular Phase II/III trials and developed an investigator network in key therapeutic areas such as cardiovascular, endocrinology and family medicine.
 
“I am delighted to welcome these two talented leaders to Frontage. I am confident they will enable Frontage to continually enhance our service offerings and offer valuable insights to our clients that help solve difficult development challenges, or optimize a clinical development pathway,” said Song Li, chairman and chief executive officer of Frontage Laboratories. “Our company foundation and success is built upon the efforts and commitment of our internal teams”
 
Frontage plans to expand its full-service early phase clinical services, which includes capabilities to conduct a broad range of clinical study types, as well as broadening protocol development, analysis methodology and reporting services supporting later phase trials and programs.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On